Cyclooxygenase-2 inhibition and cardiovascular events

被引：72
作者：
Pitt, B
Pepine, C
Willerson, JT
机构：
[1] Univ Texas, Hlth Sci Ctr, St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX 77030 USA
[2] Univ Florida, Sch Med, Gainesville, FL USA
[3] Univ Michigan, Sch Med, Ann Arbor, MI USA
来源：
CIRCULATION | 2002年 / 106卷 / 02期
关键词：
editorials; drugs; cardiovascular disease;
D O I：
10.1161/01.CIR.0000025261.58465.62
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：167 / 169
页数：3
相关论文
共 24 条
[1]   Efficacy assessment of meloxicam, a preferential cyclooxygenase-2 inhibitor, in acute coronary syndromes without ST-segment elevation - The nonsteroidal anti-inflammatory drugs in unstable angina treatment-2 (NUT-2) pilot study [J].
Altman, R ;
Luciardi, HL ;
Muntaner, J ;
Del Rio, F ;
Berman, SG ;
Lopez, R ;
Gonzalez, C .
CIRCULATION, 2002, 106 (02) :191-195
[2]   Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages [J].
Baker, CSR ;
Hall, RJC ;
Evans, TJ ;
Pomerance, A ;
Maclouf, J ;
Creminon, C ;
Yacoub, MH ;
Polak, JM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (03) :646-655
[3]   NSAIDS and selective COX-2 inhibitors: competition between gastroprotection and cardioprotection [J].
Boers, M .
LANCET, 2001, 357 (9264) :1222-1223
[4]   Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].
Bombardier, C ;
Laine, L ;
Reicin, A ;
Shapiro, D ;
Burgos-Vargas, R ;
Davis, B ;
Day, R ;
Ferraz, MB ;
Hawkey, CJ ;
Hochberg, MC ;
Kvien, TK ;
Schnitzer, TJ ;
Weaver, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528
[5]   Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice [J].
Burleigh, ME ;
Babaev, VR ;
Oates, JA ;
Harris, RC ;
Gautam, S ;
Riendeau, D ;
Marnett, LJ ;
Morrow, JD ;
Fazio, S ;
Linton, MF .
CIRCULATION, 2002, 105 (15) :1816-1823
[6]  
Catella-Lawson Francesca, 2001, American Journal of Medicine, V110, p28S
[7]   Role of prostacyclin in the cardiovascular response to thromboxane A2 [J].
Cheng, Y ;
Austin, SC ;
Rocca, B ;
Koller, BH ;
Coffman, TM ;
Grosser, T ;
Lawson, JA ;
FitzGerald, GA .
SCIENCE, 2002, 296 (5567) :539-541
[8]  
Crofford LJ, 2000, ARTHRITIS RHEUM, V43, P1891, DOI 10.1002/1529-0131(200008)43:8<1891::AID-ANR28>3.0.CO
[9]  
2-R
[10]   Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries [J].
Hennan, JK ;
Huang, JB ;
Barrett, TD ;
Driscoll, EM ;
Willens, DE ;
Park, AM ;
Crofford, LJ ;
Lucchesi, BR .
CIRCULATION, 2001, 104 (07) :820-825
123